AI tool for gastric cancer protein testing
Part of Cancer, Digestive system clinical trials.
This trial tests an artificial intelligence model that helps doctors interpret a specific protein test (CLDN18.2) in stomach cancer tissue samples. It may help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 years or older
- You must have had special staining tests done on your tumor tissue for a protein called CLDN18.2
- Your full medical records and test results must be available
- Your tissue sample must be complete and good quality for analysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an AI tool helps pathologists read your tissue samples more accurately. It's a study for people who have had a stomach biopsy or gastric cancer surgery, where digital images of the tissue are available.
This trial tests a computer-aided system used during upper endoscopy to find stomach growths that might be missed. It may help improve detection of early stomach cancer or precancerous changes.
This trial is testing a new artificial intelligence (AI) model to help doctors better identify whether gastric cancer has spread to nearby lymph nodes. If you qualify, you may help improve how this cancer is diagnosed and treated, without any extra invasive procedures.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This study tests whether an AI-assisted tool helps radiologists (doctors who read imaging scans) better interpret CT scans of gastric cancer patients. The research compares how accurately doctors read scans with and without AI help.
This study uses artificial intelligence to help doctors identify which patients undergoing a camera exam of the upper digestive tract (esophagus and stomach) are at higher risk for cancer. The AI analyzes images during the procedure to improve early detection and patient care.
Hear when a new Digestive Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.